- Home
- HAIN vs CLNN Comparison
HAIN vs CLNN Comparison
Compare HAIN & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HAIN | CLNN |
|---|---|---|
| Founded | 1993 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.7M | 57.4M |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HAIN | CLNN |
|---|---|---|
| Price | $0.76 | $3.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $2.23 | ★ $33.75 |
| AVG Volume (30 Days) | ★ 741.8K | 82.8K |
| Earning Date | 05-11-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,457,769,000.00 | $200,000.00 |
| Revenue This Year | N/A | $17.64 |
| Revenue Next Year | N/A | $19,516.77 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.48 | $3.88 |
| 52 Week High | $1.73 | $13.50 |
Technical Indicators
Market Signals| Indicator | HAIN | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 56.22 | 35.78 |
| Support Level | $0.55 | $3.92 |
| Resistance Level | $0.86 | $4.70 |
| Average True Range (ATR) | 0.08 | 0.34 |
| MACD | 0.00 | 0.02 |
| Stochastic Oscillator | 55.09 | 21.69 |
Price Performance
Historical ComparisonAbout HAIN Hain Celestial Group Inc. (The)
The Hain Celestial Group Inc is a health and wellness company. It makes natural and organic food and personal-care products. The company offers products across various categories such as snacks, baby & kids food, beverages, meal preparation, and personal care through brands like Garden Veggie Snacks, Terra chips, Garden of Eatin snacks, Hartley's Jelly, and Celestial Seasonings teas, among others. It operates under two reportable segments: North America and International. The majority of its revenue is derived from the North America segment, which represents the sale of its products in the United States and Canada. The International segment includes the sale of its products in the United Kingdom and the Western European region.
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.